CD40 Ligand Uses, Dosage, Side Effects and more
CD40 Ligand is under investigation in clinical trial NCT00053391 (Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma).
Trade Name | CD40 Ligand |
Generic | Recombinant CD40-ligand |
Recombinant CD40-ligand Other Names | CD40 ligand, Recombinant CD40-ligand |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |